Clearmind Medicine Inc (CMND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2021 | 12-2017 | |
| Operating Expenses | 3,362 | 0 |
| Operating Income | -3,362 | N/A |
| Interest Expense | 15 | 0 |
| Other Income | -3,902 | 0 |
| Pre-tax Income | -7,279 | 0 |
| Income Tax | 32 | N/A |
| Net Income Continuous | -7,310 | N/A |
| Net Income | $-7,310 | $N/A |
| EBITDA(a) | $-3,362 | $N/A |